Patent application number | Description | Published |
20080249151 | Non-nucleoside reverse transcriptase inhibitors - Compounds of formula I, wherein R | 10-09-2008 |
20080293664 | Non-nucleoside reverse transcriptase inhibitors - Compounds of formula I, wherein R | 11-27-2008 |
20090012034 | Non-Nucleoside reverse transcriptase inhibitors - Compounds of formula I, wherein R | 01-08-2009 |
20090076045 | Non-nucleoside reverse transcriptase inhibitors - Compounds of formula I, wherein R | 03-19-2009 |
20090170856 | HETEROCYCLIC ANTIVIRAL COMPOUNDS - Compounds of formula I, wherein R | 07-02-2009 |
20090306041 | Inhibitors of Bruton's tyrosine kinase - This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: | 12-10-2009 |
20100004231 | INHIBITORS OF BURTON'S TYROSINE KINASE - This application discloses 5-phenyl-1H-pyrazin-2-one derivatives according to generic Formulae I-V: | 01-07-2010 |
20100041648 | METHODS FOR TREATING RETROVIRAL INFECTIONS - The present invention provides compositions for treating an HIV infection comprising administering a compound according to formula I where Ar, R | 02-18-2010 |
20100056535 | Inhibitors of HIV-1 reverse transcriptase - The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to Formulae I and II | 03-04-2010 |
20100099659 | Inhibitors of Bruton's Tyrosine Kinase - This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-III: | 04-22-2010 |
20100222325 | Inhibitors of Bruton's Tyrosine Kinase - This application discloses 5-phenyl-1H-pyridin-2-one, 6-phenyl-2H-pyridazin-3-one, and 5-Phenyl-1H-pyrazin-2-one derivatives according to generic Formulae I-III: | 09-02-2010 |
20110059975 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS - The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein A is A2 and R | 03-10-2011 |
20110207688 | HETEROCYCLIC ANTIVIRAL COMPOUNDS - The present invention relates to a method of treating an HIV-I infection with a compound according to formula I where R | 08-25-2011 |
20120157427 | PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Compounds of the formula I: | 06-21-2012 |
20130096102 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Compounds of the formula I: | 04-18-2013 |
20130156700 | FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 - A method for positron emission tomography (PET) imaging of LRRK2 in tissue of a subject, the method comprising: administering a compound of formula I, formula II or formula III, or a pharmaceutically acceptable salt thereof to the subject, wherein the compound includes at least one C | 06-20-2013 |
20130157999 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Specific Compounds of formula I: | 06-20-2013 |
20130158006 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Compounds of the formula I: | 06-20-2013 |
20130158032 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Compounds of the formula I: | 06-20-2013 |
20130158057 | AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Compounds of the formula I: | 06-20-2013 |
20140134132 | CYCLIC PEPTIDES AND USE AS MEDICINES - The present invention provides a compound of formula I; | 05-15-2014 |
20150051238 | PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS - Pyrazole compounds that are modulators of LRRK2, methods of making the compounds, and methods for using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease. | 02-19-2015 |